Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PANCREAZE ® safely and effectively. See full prescribing information for PANCREAZE ®. PANCREAZE ® (pancrelipase) delayed-release capsules Initial U.S. Approval: 2010
Medication labelWhy this: Advisory · dailymed-prescription
PANCREAZE is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
- generic_name
- pancrelipase lipase, pancrelipase amylase, and pancrelipase protease
- product_names
- PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
- ndc
- 62541-401, 62541-402, 62541-403, 62541-404, 62541-405, 62541-406, 62541-402-10, 62541-403-10, 62541-404-10, 62541-405-10, 62541-401-10, 62541-406-50, 62541-406-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en